Pharmaceutical Studies: organizations & projects
AdWatch
AdWatch is a monthly webpage designed to help doctors, pharmacists and the
public defend ourselves from misleading drug promotion illuminating the
logical, psychological and pharmacological techniques used in drug advertisements.
AdWatch also provides practical recommendations for optimal medical care.
AdWatch is produced by Healthy Skepticism, Inc., an international non-profit
organisation aiming to improve health by reducing harm from drug promotion.
Center
for Pharmaceutical Management -- Management Sciences for Health
The Center continues its commitment to providing high-quality technical
assistance and training in pharmaceutical management worldwide. The Center
works closely with both senior and operations-level personnel in developing
countries to build or improve the infrastructure needed to effectively purchase,
store, deliver, and use quality, essential medicines.
Health
Action Internation (HAI) Europe's Campaign on Direct-to-Consumer Advertising
of Prescription Medicines
This page consists of three sections: Developments; Media attention on the
issue; Position papers by campaign partners.
International
Journal of Drug Policy
IJDP seeks to publish material on the social, political, legal, and
health contexts of psychoactive substance use, both licit and illicit. The
journal is particularly concerned to explore the effects of drug policy
and practice on drug-using behaviour and its health and social consequences.
It is the policy of the journal to represent a wide range of material on
drug-related matters from around the world.
International
Society of Drug Bulletins
a world wide network of bulletins and journals on drugs and therapeutics
that are financially and intellectually independent of pharmaceutical industry.
It was founded in 1986, with the support of the WHO Regional Office for
Europe.
Médecins
Sans Frontières (MSF) Campaign for Access to Essential Medicines
MSF is advocating for a combination of policies to lower drug prices on
a sustainable basis; these strategies include encouraging generic competition,
voluntary discounts on branded drugs, global procurement, and local production.
MSF is also pushing for increased research into neglected diseases –
such as tuberculosis, malaria, sleeping sickness, and leishmaniasis –
through increased funding, investing in R&D capability in developing
countries, and supporting alternative models for R&D.
Pharmaceutical
Management -- Center for International Health, Boston University School
of Public Health
The drug use intervention research portfolio is co-funded by several organizational
sponsors based on the research priorities that emanated from the 1997 International
Conference on Improving Use of Medicines (ICIUM). Through this initiative,
the collaborating partners shape and provide technical leadership to the
global agenda on improving use of medicines. The aims of the Joint Research
Initiative are to: Increase capacity to conduct interventions in developing
countries; Stimulate a critical mass of research projects in identified
priority areas; and identify and actively disseminate successful intervention
approaches.
Women and
Health Project/Action pour la protection de la santé des femmes
WHP is a coalition of community groups, researchers, journalists and activists
concerned about the safety of pharmaceutical drugs. The group keeps a close
watch over the proposed changes in the federal health protection legislation
and examines the impact of those changes on women's health. Their documents
make clear recommendations to the government demanding that Canadian legislation
truly provide "health protection".
United States
Pharmacopeia (USP)
The USP, in cooperation with the U.S. Agency for International Development
(USAID), manages the Drug Quality and Information (USP DQI) Program to support
delivery of priority interventions for the USAID Center for Population,
Health, and Nutrition. USP DQI focuses on ensuring the quality of pharmaceuticals
and their informed and appropriate use worldwide.